Clinical trials
Every registered trial of Tirzepatide
260 studies, 123 still enrolling.
Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Tirzepatide has been studied in people a great deal.
- 260 registered studies in total.
- 123 are still enrolling people, so this is active research, not just history.
What kind of research
- 229 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 90,221 people took part in those.
- A further 31 studies only looked at records of people already taking it. These are counted separately because nobody was given the peptide for the study, so they cannot prove cause and effect.
How far along it is
- 89 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
- 53 have published results in the medical literature that anyone can read.
- The research spans 54 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 260 of 260 trials for Tirzepatide.
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
Royal North Shore Hospital
Type 1 Diabetes Mellitus · Overweight and Obesity
Trial of Tirzepatide for the Treatment of Cannabis Use Disorder
National Institute on Drug Abuse (NIDA)
Cannabis Use Disorder
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
National Cancer Institute (NCI)
Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia · FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals
Acibadem University
Obesity · Sarcopenia · Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
University of Chicago
Lung Cancer
Tirzepatide for Treatment of CCCA
Johns Hopkins University
Central Centrifugal Cicatricial Alopecia (CCCA)
Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients
Yunlong Wang
Atrial Fibrillation · Obesity & Overweight · Catheter Ablation
Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
University of North Carolina, Chapel Hill
Pouch, Ileal · Pouches, Ileoanal · Bowel Diseases, Inflammatory
GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
The Cleveland Clinic
COPD · Obesity & Overweight · Sarcopenia
An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
University of Texas Southwestern Medical Center
Obesity · Methamphetamine Use Disorder · Cocaine Use Disorder · Stimulant Use Disorders
Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide
Technical University of Munich
Obesity (BMI>30)
Salivary Function and Dental Changes During GLP-1 Therapy
Bilecik Seyh Edebali Universitesi
Obesity · Dental Erosion · Saliva Collection · Saliva Altered
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
Biomed Industries, Inc.
Obesity and Overweight
RESIST-26-HAL-0150-I
Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)
Obesity
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
Akhtar Saeed Medical and Dental College
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
yifang zhu
Acute Ischemic Stroke (AIS)
Comparing Facial Aging Between Identical Twins With 3D Imaging
Ponsky Facial Aesthetics And Plastic Surgery, Llc
Facial Skin Aging · Facial Volume Loss · Wrinkle Appearance
Incretin Therapies in Obesity-related HFpEF
Columbia University
Heart Failure, Diastolic · Heart Failure With Preserved Ejection Fraction · Obesity
A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants
Shanghai Zhongshan Hospital
Obesity Adult Onset
Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Obesity & Overweight
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Endometrial Cancer · Endometrial Intraepithelial Neoplasia · Grade 1 Endometrial Endometrioid Carcinoma
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
Yunlong Wang
Atrial Fibrillation · Heart Failure With Preserved Ejection Fraction (HFpEF) · Tirzepatide
The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
University of Virginia
Obesity & Overweight
Tirzepatide in Idiopathic Intracranial Hypertension Trial
Duke University
Idiopathic Intracranial Hypertension (IIH)
Tirzepatide in the Treatment of Cannabis Use Disorder
McMaster University
Cannabis Use Disorder, Moderate · Cannabis Use Disorder, Severe
Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial
Universitaire Ziekenhuizen KU Leuven
Hormone-receptor-positive Breast Cancer · Early Breast Cancer
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
Alaa Sada
Mild Autonomous Cortisol Secretion (MACS) · Adrenalectomy; Status
Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
Las Rías Medical Center
Obesity · Diabetes Mellitus, Type 2
AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
The First Affiliated Hospital of Anhui Medical University
Obesity · Diabetes Mellitus, Type 2
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
Shahid Beheshti University of Medical Sciences
Heart Failure and Reduced Ejection Fraction · Obesity & Overweight · Tirzepatide
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
Victor Chang Cardiac Research Institute
Type 1 Diabetes Mellitus
Tirzepatide for the Treatment of Cannabis Use Disorder
Brigham and Women's Hospital
Cannabis Use Disorder
Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy
Post Graduate Institute of Medical Education and Research, Chandigarh
Neuropathy, Small Fiber · Diabete Mellitus
New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
Sun Yat-sen University
Diabetes Mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Preoperative Optimization With Tirzepatide, Ketogenic Diet, or Standard Care Before One Anastomosis Gastric Bypass Surgery
Mario Musella MD
Obesity (BMI > 35) and Diabetes Mellitus · Obesity (BMI > 35) and Dyslipemia · Obesity (BMI > 35) and High Blood Pressure
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV
National Taiwan University Clinical Trial Center
Human Immunodeficiency Virus (HIV) · Metabolic Dysfunction Associated Steatotic Liver Disease · Dyslipidaemia · Diabetes Mellitus
Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation
National Taiwan University Hospital
Atrial Fibrillation Ablation · Persistent Atrial Fibrillation · Obesity & Overweight
Tirzepatide in MetALD
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Metabolic Alcohol-associated Liver Disease · Alcohol Use Disorder
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Weill Medical College of Cornell University
Obesity (Disorder) · Breast Cancer
Multi-Site Trial of Tirzepatide for Smoking Cessation
University of Southern California
Smoking Cessation · Smoking Behaviors
Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
The University of Texas at Dallas
Drug Discontinuation · Substance Use Disorders · Eating Behavior Changes · Tirzepatide
Tirzepatide in the Treatment of Endometrial Cancer
Rutgers, The State University of New Jersey
Endometrial Cancer
Genetic, Microbiological and Behavioral Factors in Obesity
Jan Kochanowski University
Obesity & Overweight · Obesity · Genetics
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Regeneron Pharmaceuticals
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Alcohol Use Disorder (AUD)
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
McGill University Health Centre/Research Institute of the McGill University Health Centre
Type 1 Diabetes · Type 1 Diabetes Mellitus · T1D · T1DM
Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity
Dasman Diabetes Institute
Obesity
CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
JULIO GRANADOS MONTIEL
Psoriatic Arthritis · Osteoarthitis · Knee · Diabetes (DM)
Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health
First Affiliated Hospital of Wenzhou Medical University
Obesity-related Male Infertility
GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity
China-Japan Friendship Hospital
Obesity
GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study
Noom Inc.
Obesity & Overweight · Weight Loss · Preventative Health · Body Weight
AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)
Huazhong University of Science and Technology
Overweight or Obesity; Type 2 Diabetes · Weight Loss Maintenance
Tirzepatide in Obesity-Driven Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Endometrial Cancer · Obesity
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
St. Jude Children's Research Hospital
Acute Lymphoblastic Leukemia · Obesity
The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
Mayo Clinic
Obesity · Menopause Hot Flashes
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
The University of Texas Health Science Center at San Antonio
Obesity Prevention · Sarcopenia in Elderly · Cardiovascular Function · GLP - 1
Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity
Radboud University Medical Center
Overweight , Obesity · Obesity (Disorder)
Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Obesity
Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs
Tri-Service General Hospital (TSGH)
Obesity and Metabolic Syndrome
N1T-MC-MALO
Eli Lilly & Co.
Metabolic Dysfunction-Associated Steatotic Liver Disease
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
NHS Greater Glasgow and Clyde
Psoriatic Arthritis (PsA) · Obesity & Overweight
A Study to Evaluate ALN-2232 in Participants With Obesity
Alnylam Pharmaceuticals
Obesity
DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies
Cambridge University Hospitals NHS Foundation Trust
Cardiovascular Diseases
Safety and Effectiveness of Tirzepatide in Patients With Obesity at Hospital de Clínicas, Paraguay
LABORATORIOS INDUFAR
Obesity · Type 2 Diabetes Mellitus · Overweight With Comorbidities
A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
Eli Lilly and Company
Diabetes Mellitus, Type 2 · Obesity · Overweight
Tirzepatide to Slow Biological Aging
The University of Texas Medical Branch, Galveston
Aging · LONGEVITY 1
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
Massachusetts General Hospital
Colorectal Cancer Prevention · Colorectal Adenoma
Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.
Brigham and Women's Hospital
Obesity · Overweight
A phase 2, safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy study of a subcutaneous injection of BC-006 and tirzepatide in adults with obesity
BaseCure Therapeutics Inc.
Obesity
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)
Hudson Biotech
Obesity · Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities
Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure
Shahid Beheshti University of Medical Sciences
Obesity
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
T. John Winhusen, PhD
Opioid Use Disorder · Opioid Use Disorder, Moderate · Opioid Use Disorder, Severe
INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
Brigham and Women's Hospital
Type 2 Diabetes · Overweight · ASCVD
Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study
Hospital Israelita Albert Einstein
Full Stomach Status
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease
University Medical Centre Ljubljana
Obesity & Overweight · Adult Congenital Heart Disease
IIH-Advance: A randomised clinical trial to determine the effects of weight loss, induced by a weight loss drug (Tirzepatide), in adults with active idiopathic intracranial hypertension
University of Birmingham
Idiopathic intracranial hypertension
Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
South West Sydney Local Health District
Alcohol Use Disorder (AUD) · Overweight or Obese · Comorbidities and Coexisting Conditions
A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus
Eli Lilly and Company
Diabetes Mellitus, Type 2 · Overweight · Obesity
Tirzepatide (Spartina) in Obese Kidney Transplant Recipients
Shahid Beheshti University of Medical Sciences
Tirzepatide
A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults
Cambridge University Hospitals NHS Foundation Trust
Hypertension · Obesity & Overweight
Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes
Indiana University
Obesity
Tirzepatide and Muscle Outcomes in Obesity
University Medical Centre Ljubljana
Obesity (Disorder)
Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity
Istanbul Galata University
Obesity
A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
University of Bonn
Polycystic Ovary Syndrome (PCOS) · Obesity & Overweight
MED1-202202
Rheinische Friedrich-Wilhelms-Universitaet Bonn
Overweight or Obesity, Polycystic Ovary Syndrome (PCOS)
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
Eli Lilly and Company
Obesity
Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
University of Hawaii
Obesity and Overweight · HIV · Chronic Inflammation
Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity
Massachusetts General Hospital
Obesity
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
City of Hope Medical Center
Prostate Carcinoma · Recurrent Prostate Carcinoma
Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity
Ikaria Bioscience Pty Ltd
Obesity &Amp; Overweight
The Long COVID Treatment Trial
Scripps Translational Science Institute
Long COVID
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Eli Lilly and Company
Metabolic Dysfunction-Associated Steatotic Liver Disease
GLP-1R Actions on Muscle and the Skeleton
Pennington Biomedical Research Center
Musculoskeletal Abnormalities · Obesity · Sarcopenic Obesity · Osteoporosis
Tirzepatide for Alcohol Use Disorder
University of Southern California
Alcohol Use Disorder · Obesity and Overweight · Alcohol
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
Mayo Clinic
Obesity
Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
Brigham and Women's Hospital
Type2 Diabetes Mellitus · Atherosclerotic Cardiovascular Disease
I6T-MC-AMCE
Eli Lilly & Co.
Crohn’s Disease, Obesity or Overweight
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
Johns Hopkins University
Obesity and Overweight · Binge Eating Disorder
Study of Tirzepatide for Recovery and Alcohol Use Management
Brigham and Women's Hospital
Alcohol Use Disorder (AUD)
Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
University of Michigan
Lipodystrophy, Partial
Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
Dr. Md. Alimur Reza
Obesity
Comparison of Body Composition Changes With Weight Loss Interventions
Vanderbilt University Medical Center
Obesity
Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium
University Health Network, Toronto
Endometrial Cancer · Atypical Hyperplasia
Tirzepatide Use in People With Obesity and Type 1 Diabetes
Dasman Diabetes Institute
Type1diabetes · Obesity
GLP-1s to Enhance Lasting Optimal Weight
Wake Forest University Health Sciences
Obesity
BC45538
F. Hoffmann-La Roche AG
Obesity
A phase 1, safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of a subcutaneous injection of BC-006 in adults with obesity-part 2
BaseCure Therapeutics Inc.
Diet and Nutrition
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
M.D. Anderson Cancer Center
Diabetes · Prostate Cancer
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
University of New Mexico
MASLD · Obesity
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Eli Lilly and Company
Crohn's Disease · Obesity or Overweight
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Eli Lilly and Company
Ulcerative Colitis · Obesity or Overweight
Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity
Innovent Biologics (Suzhou) Co. Ltd.
Obesity
Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity
Second Affiliated Hospital, Zhejiang University, School of Medicine
Adults With Simple Obesity
A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
Eli Lilly and Company
Obesity · Overweight
Tirzepatide vs Liraglutide in Bone
National and Kapodistrian University of Athens
Obesity (Disorder)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
Washington University School of Medicine
Crohn Disease (CD)
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
Eli Lilly and Company
Type 1 Diabetes · Obesity · Overweight
A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Arrowhead Pharmaceuticals
Obesity · Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
Hoffmann-La Roche
Obesity · Overweight · Overweight With One Weight Related Comorbidity
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Anders Fink-Jensen, MD, DMSci
Alcohol Use Disorder · Alcohol Abuse/Dependence · Alcohol Dependence · Alcoholism
Tirzepatide in PWS, HO and GNSO
Grace Kim
Prader-Willi Syndrome · Hypothalamic Obesity · Obesity/Therapy
Effect of tirzepatide on alcohol intake and reward processing in patients diagnosed with schizophrenia and alcohol use disorder
Psykiatrisk Center Kobenhavn
Schizophrenia and Alcohol Use Disorder
Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women
Mayo Clinic
Obesity · Menopause
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
Eli Lilly and Company
Type 1 Diabetes · Obesity · Overweight
A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
Eli Lilly and Company
Overweight · Obesity
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
The Cleveland Clinic
Atrial Fibrillation · Obesity
A Study of BGM0504 in Participants With Obesity
BrightGene Bio-Medical Technology Co., Ltd.
Obesity
Prevent from home: young person and buddies’ cardiovascular health improvement feasibility study
King's College London
Hypertension in pregnancy, gestational diabetes
2024 Tirzepatide-Bariatric Surgery
Marlene Starr
Obesity and Obesity-related Medical Conditions · Bariatric Surgery
A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants
Eli Lilly and Company
Healthy
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Eli Lilly and Company
Psoriasis · Overweight or Obesity
Effect of Tirzepatide on Brown Adipose Tissue in Obesity
University Medical Centre Ljubljana
Obesity
Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss
Nicholas Skertich
Obesity and Obesity-related Medical Conditions
Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
University of Colorado, Denver
Autosomal Dominant Polycystic Kidney · Obesity
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Eli Lilly and Company
Psoriatic Arthritis · Overweight or Obesity
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
University of Miami
Crohn Disease
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
Gan and Lee Pharmaceuticals, USA
Obesity and Overweight
GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
University of Bern
Type 1 Diabetes (T1D)
Tirzepatide for Obesity and Meth Use Disorder
University of Texas Southwestern Medical Center
Obesity · Methamphetamine Use Disorder
Real-World Tirzepatide Therapy in Post-Bariatric Weight Regain and Preoperative Obesity Patients
Azienda Sanitaria Locale Napoli 2 Nord
Obesity & Overweight · Weight Regain · Obesity, Morbid
Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events
Ariel University
Obesity; Drug
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Bariatric Surgery vs. Semaglutide vs. Tirzepatide
Ali Aminian
Obesity and Obesity-related Medical Conditions
Investigating and optimising physical function with weight loss
University of Leicester
Overweight or obesity
Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims Data
Brigham and Women's Hospital
Diabetes Mellitus, Type 2 · Heart Failure With Preserved Ejection Fraction (HFPEF)
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction
Brigham and Women's Hospital
Diabetes Mellitus, Type 2 · HFpEF - Heart Failure With Preserved Ejection Fraction
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
Stanford University
Diabetes Mellitus, Type 2 · Diabetes · Type 2 Diabetes · Pre Diabetes
Efficacy and Safety of Tirzepatide for Weight Management
Chittagong Medical College
Obesity and Obesity-related Medical Conditions
Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
Brigham and Women's Hospital
Type 2 Diabetes · Heart Failure
Tirzepatide-Based Prehabilitation Before Elective Ventral and Incisional Hernia Repair in Patients With Obesity
Azienda Sanitaria Locale Napoli 2 Nord
Obese Adults · Hernia Abdominal Wall · Prehabilitation
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Endometrial Cancer
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs
Nazarbayev University
Heart Failure · Diabete Type 2 · Arterial Hypertension
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Arrowhead Pharmaceuticals
Obesity
Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants
Lexaria Bioscience Corp.
Type2diabetes
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
Baylor Research Institute
Breast Cancer · Breast Neoplasms · Breast Cancers
Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
University of Melbourne
Obesity · Knee Osteoarthritis · Osteoarthritis, Knee
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
The University of Texas Health Science Center at San Antonio
Type 2 Diabetes (Adult Onset)
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Brigham and Women's Hospital
Type 2 Diabetes
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Eli Lilly and Company
Obesity
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
University of California, Davis
Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
Vanderbilt University Medical Center
Severe Obesity · Obesity · BMI Greater Than 30
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
Rutgers, The State University of New Jersey
Hormone Receptor-Positive Breast Cancer · HER2-Negative Breast Cancer
J1I-MC-GZBP
Eli Lilly & Co.
Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
Eli Lilly and Company
Obesity · Overweight
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
Eli Lilly and Company
Type 2 Diabetes
Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data
Brigham and Women's Hospital
Type 2 Diabetes · Major Adverse Cardiac Events · Cardiovascular (CV) Risk
Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
Brigham and Women's Hospital
Type 2 Diabetes · Overweight · Cardiovascular (CV) Risk
The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
Tina Vilsbøll
Coronary Artery Disease · Coronary Microvascular Dysfunction · Overweight or Obesity · Stable Angina Pectoris
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
Eli Lilly and Company
Psoriasis · Obesity
I8F-MC-GPIX
Eli Lilly & Co.
Obesity
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
Eli Lilly and Company
Psoriatic Arthritis · Obesity
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Eli Lilly and Company
Obesity · Overweight
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
University of Kansas Medical Center
Obesity · Breast Cancer Risk
The effects of tirzepatIDE on coronAry pLaque lipid content and myocardial microvascular function in people with overweight or obesity and CORonary disease
Steno Diabetes Center Copenhagen
Overweight and obesity
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Palatin Technologies, Inc
Obesity
The effectiveness and sustainability of health outcomes from an advanced digital weight-loss programme in the UK
Eucalyptus
Overweight and obesity
Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
The Cleveland Clinic
Diabetes Mellitus, Type 2 · Obesity · Gastroparesis
Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over
BioAge Labs, Inc.
Obesity
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Eli Lilly and Company
Obesity · Weight Gain
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
Scholar Rock, Inc.
Overweight and Obesity
Towards a personalized precision medicine in rare disease: tirzepatide (a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist) monotherapy in patients with Wolfram syndrome type 1.
Ospedale San Raffaele S.r.l.
Wolfram syndrome type 1
GLP-1 Medicines and Mental Health Changes
University of California, San Diego
Obesity · Depression · GLP-1
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Eli Lilly and Company
Obesity
A Study of LY3841136 in Japanese Participants With Obesity or Overweight
Eli Lilly and Company
Obesity · Overweight
A Study of LY3841136 in Overweight and Obese Participants
Eli Lilly and Company
Obesity · Overweight
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
Novo Nordisk A/S
Obesity
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa
Florida Academic Centers Research and Education, LLC
Hidradenitis Suppurativa
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Novo Nordisk A/S
Type 2 Diabetes
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
Matthew J. Budoff
Type II Diabetes · Atherosclerosis
Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
Ospedale San Raffaele
Wolfram Syndrome
Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity
Goztepe Prof Dr Suleyman Yalcın City Hospital
Steatosis of Liver · Metabolic Liver Injury · Obesity · Overweight
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
Novo Nordisk A/S
Obesity
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Eli Lilly and Company
Obesity · Overweight
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
Stanford University
Obesity · Overweight and Obesity · Overweight
A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Eli Lilly and Company
Obesity · Overweight
Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
Dr Adnan Agha
Non-Alcoholic Fatty Liver Disease · Non-alcoholic Steatohepatitis · Type 2 Diabetes · Liver Fat
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Eli Lilly and Company
Type 2 Diabetes · Obesity
A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Eli Lilly and Company
Overweight · Obesity
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Cardenal Herrera University
Chronic Kidney Disease stage3 · Chronic Kidney Disease stage4 · Chronic Kidney Disease Stage 1 · Chronic Kidney Disease Stage 2
Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
Washington University School of Medicine
Obesity · Metabolic Disease
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Eli Lilly and Company
Type 2 Diabetes
A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
Eli Lilly and Company
Healthy
The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.
CorEvitas
Metabolic Health
Anti-obesity Pharmacotherapy and Inflammation
Louisiana State University Health Sciences Center in New Orleans
Obesity
Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
OrsoBio, Inc
Healthy Subjects · Obesity · Type 2 Diabetes
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
Eli Lilly and Company
Obesity · Overweight
A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices
Eli Lilly and Company
Healthy
A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)
Eli Lilly and Company
Type 2 Diabetes · Diabetes Mellitus, Type 2
I8F-MC-GPIG
Eli Lilly & Co.
Obesity, Overweight, CKD, Chronic Kidney Disease, T2D, Type 2 Diabetes
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Eli Lilly and Company
Overweight · Obesity · Chronic Kidney Disease · Type 2 Diabetes
A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
Eli Lilly and Company
Obesity
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Eli Lilly and Company
Diabetes Type 2 · Diabetes Mellitus · Glucose Metabolism Disorders · Metabolic Disease
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
Eli Lilly and Company
Type 2 Diabetes
A Study of LY3457263 in Obese Participants
Eli Lilly and Company
Overweight · Obesity
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
Eli Lilly and Company
Obesity · Overweight
Role Of Metabolic Adaptation In Weight Regain
Pennington Biomedical Research Center
Weight Loss · Weight Gain · Obesity
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
Eli Lilly and Company
Type 2 Diabetes
Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
Eli Lilly and Company
Obstructive Sleep Apnea · Obesity
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
Eli Lilly and Company
Type2 Diabetes · Diabetes Mellitus · Diabetes Mellitus, Type 2 · T2D
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
Nanjing First Hospital, Nanjing Medical University
Type 2 Diabetes Mellitus
A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
Eli Lilly and Company
Obesity · Overweight · Metabolism and Nutrition Disorder
A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
Eli Lilly and Company
Obesity
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
Eli Lilly and Company
Obesity · Heart Failure With Preserved Ejection Fraction (HFpEF)
A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
Eli Lilly and Company
Obesity · Overweight
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
Eli Lilly and Company
Type 2 Diabetes · Overweight · Obesity
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
Eli Lilly and Company
Obesity · Overweight
A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus
Eli Lilly and Company
Diabetes Mellitus, Type 2
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
Eli Lilly and Company
Type 2 Diabetes
A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
Eli Lilly and Company
Overweight · Obesity · Diabetes Mellitus, Type 2
A Study of Tirzepatide in Overweight and Very Overweight Participants
Eli Lilly and Company
Obesity · Overweight
Study of Tirzepatide in Healthy Participants
Eli Lilly and Company
Healthy
A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
Eli Lilly and Company
Obesity
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Eli Lilly and Company
Type 2 Diabetes Mellitus
A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants
Eli Lilly and Company
Healthy
A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus
Eli Lilly and Company
Diabetes Mellitus, Type 2 · Hypoglycemia
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
Eli Lilly and Company
Type 2 Diabetes
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Eli Lilly and Company
Overweight · Obesity
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Eli Lilly and Company
Nonalcoholic Steatohepatitis
A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes
Eli Lilly and Company
Healthy
A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
Eli Lilly and Company
Type 2 Diabetes
A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
Eli Lilly and Company
Healthy
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
Eli Lilly and Company
Type 2 Diabetes
A Study of Tirzepatide in Participants With Impaired Liver Function
Eli Lilly and Company
Hepatic Insufficiency
A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
Eli Lilly and Company
Diabetes Mellitus, Type 2
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
Eli Lilly and Company
Type 2 Diabetes Mellitus
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
Eli Lilly and Company
Type 2 Diabetes
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
Eli Lilly and Company
Type 2 Diabetes Mellitus
A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
Eli Lilly and Company
Type 2 Diabetes Mellitus
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
Eli Lilly and Company
Type 2 Diabetes Mellitus
A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
Eli Lilly and Company
Renal Insufficiency · End Stage Renal Disease
A Study of Tirzepatide (LY3298176) in Healthy Participants
Eli Lilly and Company
Healthy
A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes
Eli Lilly and Company
Type 2 Diabetes Mellitus
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
Eli Lilly and Company
Type 2 Diabetes
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
Eli Lilly and Company
Type 2 Diabetes Mellitus
A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
Eli Lilly and Company
Healthy · Type 2 Diabetes Mellitus (T2DM)
17203
Eli Lilly & Co.
Obesity Overweight
CRC.0007
University College Dublin
Endometrial adenocarcinoma
SAMUEL
Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre
Obstructive sleep apnea syndrome, Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Efficacy and safety of pharmacological therapy of obesity in liver transplant candidates
Institute For Clinical And Experimental Medicine
Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Tirzepatide is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.